Research On The Development Strategy Of A Pharmaceutical Co.,Ltd.

Since 2016,China has successively emphasized the importance of the traditional Chinese medicine industry from the policy level,and under the multiple backgrounds of the landing of new medical reform,the acceleration of aging trends and the high incidence of chronic diseases,the goal of encouraging the combination of medical and nursing care,technological innovation,cross-border integration,and promoting the upgrading of traditional Chinese medicine-related industrial chains has become more and more urgent.At the same time,China’s economy has clearly changed from a high-speed growth stage to a high-quality development stage,and the application of the Internet,Internet of Things,big data and artificial intelligence in the pharmaceutical field will fundamentally change the traditional offline diagnosis and treatment mode,and the impact of the epidemic has promoted the rapid development of this field.As an emerging market with the largest economy in the world,China is also the world’s second largest pharmaceutical market,with the support of national policies,the spread of traditional Chinese medicine health culture,the strengthening of residents’ awareness of health care,the traditional Chinese medicine industry as an important branch of the pharmaceutical field,coupled with the advantages in chronic disease management and outstanding contributions during the epidemic period,it can be reasonably predicted that its future development prospects will be good,the industry will extend widely,and it has unlimited potential.However,in such a favorable context,A Pharmaceutical Co.,Ltd.,as a private enterprise in Yunnan with a history of more than 100 years and the main body of traditional Chinese medicine chain pharmacies and traditional Chinese medicine diagnosis and treatment institutions,in 2016-2020,sales revenue declined year by year,and the profit level was not optimistic-compared with the upward trend of continuous growth in the pharmaceutical retail industry in the past five years,the company is obviously in a state of contraction.Based on this,this paper studies the macro environment,industry environment and its own business situation of Company A under the background of high-quality development of traditional Chinese medicine in the current and future medium and long term through case analysis,literature research and comparative analysis..Using the strategic management and related knowledge learned during the postgraduate period to conduct research and analysis on the above content,it is concluded that the overall strategic level of company A should choose intensive and related diversified development strategies,and the competitive strategy level should adopt a strategy of combining differentiation and concentration The functional strategy level mainly focuses on marketing management,production management,human resource management,etc.,in order to solve old problems,adapt to the new environment,base on traditional advantages,and grasp development opportunities.